drugset / Trial / NCT06902974
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
NaSingle-groupOpen-labelTreatment
Summary
A Phase 2, Open-Label Study to explore the efficacy, safety, and tolerability of psilocybin-assisted therapy in women with sexual assault-related Posttraumatic Stress Disorder (PTSD).
Timeline
- Start
- 2026-05-23
- Primary completion
- 2027-11
- Completion
- 2028-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | Oral |